Literature DB >> 1717970

Anxiety in women with low maternal serum alpha-fetoprotein screening results.

D N Abuelo1, M R Hopmann, G Barsel-Bowers, A Goldstein.   

Abstract

The purpose of this study was to measure anxiety in pregnant women who had low maternal serum alpha-fetoprotein (MSAFP) screening test levels, received genetic counselling and chose to undergo amniocentesis for fetal chromosome analysis. Their anxiety levels were compared with the levels in women undergoing amniocentesis because of advanced maternal age. The results indicate a higher level of anxiety in women with low alpha-fetoprotein (AFP) levels.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1717970     DOI： 10.1002/pd.1970110607

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN： 0197-3851            Impact factor:   3.050


  9 in total

1.  Attitudes toward maternal serum screening in Chinese women with positive results.

Authors:  Sheau-Wen Jan; Chih-Ping Chen; Lian-Hua Huang; Fu-Yuan Huang; Chung-Chi Lan
Journal:  J Genet Couns       Date:  1996-12       Impact factor: 2.537

2.  To Use or Not to Use: The Prenatal Genetic Technology/Worry Conundrum.

Authors:  R Kenen; A C Smith; C Watkins; C Zuber-Pittore
Journal:  J Genet Couns       Date:  2000-06       Impact factor: 2.537

3.  Assessment of the Effectiveness of Genetic Counseling by Telephone Compared to a Clinic Visit.

Authors:  Karan K Sangha; Anita Dircks; Sylvie Langlois
Journal:  J Genet Couns       Date:  2003-04       Impact factor: 2.537

4.  Update and Review: Maternal Serum Screening.

Authors:  K E Ormond
Journal:  J Genet Couns       Date:  1997-12       Impact factor: 2.537

5.  Rapid prenatal diagnosis of chromosomal aneuploidies by fluorescence in situ hybridization: clinical experience with 4,500 specimens.

Authors:  B E Ward; S L Gersen; M P Carelli; N M McGuire; W R Dackowski; M Weinstein; C Sandlin; R Warren; K W Klinger
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

6.  Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy.

Authors:  D N Rausch; G M Lambert-Messerlian; J A Canick
Journal:  West J Med       Date:  2000-09

7.  Impact of increased risk for fetal aneuploidy on maternal mood: a prospective longitudinal study.

Authors:  Dayna L Nevay; Catriona Hippman; Angela Inglis; Arianne Albert; Jehannine Austin
Journal:  Acta Obstet Gynecol Scand       Date:  2016-08-17       Impact factor: 3.636

8.  Pre-screening education in multiple marker screening programs: The effect on patient anxiety and knowledge.

Authors:  K E Ormond; E Pergament; B A Fine
Journal:  J Genet Couns       Date:  1996-06       Impact factor: 2.537

9.  Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.

Authors:  P T Dick
Journal:  CMAJ       Date:  1996-02-15       Impact factor: 8.262
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.